Dexcom Report at ATTD 2025: HCPs Favor Tech Over Medication
DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the “Dexcom State of Type 2 Report:...
Category : Healthcare and Pharmaceutical
Atropos Health Adds Federated Nodal Deidentification to GENEVA OS™
New proprietary technology enables federated multi-nodal queries, safe harbor encoding, and cross-node query without requiring data transfer to promote enhanced data possession and security footing...
Sapio Sciences Integrates NVIDIA BioNeMo for AI-Driven Drug Discovery
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the...
Humanetics Chooses Lifecore for BIO 300 CDMO Services
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical...
RedHill Biopharma to Submit Talicia® for UK Approval
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA’s2 new fast-track approval process, referencing FDA approval, with potential UK approval in Q4/25 Listed...
Celex Oncology Unveils New Cancer Treatment at Bio-Europe 2025
Celex Oncology, a UK biotechnology company founded in 2017 and on the brink of launching the fourth revolution in cancer care, today announced the Celex...
Pills2Me Hits 1M Deliveries, Announces Nationwide Launch
Pills2Me, the rapidly growing on-demand prescription delivery service, today announced its nationwide rollout, set to begin in Q2 of 2025. This ambitious expansion follows a...
EAACI Congress 2025: Breaking Boundaries in Allergy & Immunology
The European Academy of Allergy and Clinical Immunology (EAACI) proudly presents the EAACI Congress 2025, set to take place June 13-16 in Glasgow, United Kingdom....
Chance Pharma Secures Funding to Advance Inhalation Therapies
Chance Pharmaceuticals (“Chance Pharma”), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced the successful completion of a...
iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board
iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its...
Topas Therapeutics Publishes Data on Tolerance Induction Platform
Topas Therapeutics today announced the publication of data highlighting the ability of its proprietary antigen-coupled nanoparticles’ to achieve tolerance induction in relevant autoimmune disease models, under...
Murata Unveils World’s First Metal Cell Fractionation Filter
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced “CELLNETTA,” the world’s first*1 metal cell fractionation filter designed...
SolasCure Enrolls First Patient in Phase II Aurase Trial
Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers...
PatchMD Launches GLP-1 Support Patches for Weight Loss Meds
PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support Patch Collection—a targeted solution designed to...
Josh Bersin: Skills Development Grows More Complex Yet Essential
The Josh Bersin Company, the world’s most trusted HR advisory firm, today publishes a practical guide for CHRO and L&D leaders on the future of skills...